#nb_1_8_1 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #nb_1_8_1, aggregated by home.social.
-
Here's the latest variant picture for the United States, to mid-March.
The XFG.* "Stratus" variant remained dominant, but fell to 67%.
NB.1.8.1.* "Nimbus" grew to 19%.
-
Here's the latest variant picture for the United States, to early March.
The XFG.* "Stratus" variant remained dominant, steady at 73%.
NB.1.8.1.* "Nimbus" fell to 14%.
-
Here's the latest variant picture for the United States, to late February.
The XFG.* "Stratus" variant remained dominant, steady at 72%.
NB.1.8.1.* "Nimbus" grew to 17%.
-
Here's the latest variant picture for the United States, to mid-February.
The XFG.* "Stratus" variant remained dominant, but fell to 71%.
NB.1.8.1 "Nimbus" grew slightly to 14%.
-
Here's the latest variant picture for the United States, to early February.
The XFG.* "Stratus" variant continued it’s dominance, roughly flat at 75% frequency.
NB.1.8.1 "Nimbus" was also flat at 13%.
-
Here's the latest variant picture for the United States, to mid-January.
The XFG.* "Stratus" variant continued it’s dominance, but fell to 71% frequency.
NB.1.8.1 "Nimbus" grew to 15%.
#COVID19 #SARSCoV2 #USA #XFG #Stratus #NB_1_8_1 #Nimbus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20USA.pdf
🧵 ends -
Here's the latest variant picture for New Zealand, to late January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at only 11%.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20NZ.pdf -
Here's the latest variant picture for the United States, to mid-January.
The XFG.* "Stratus" variant continued it’s dominance, falling slightly to 74% frequency.
NB.1.8.1 "Nimbus" was roughly flat at 12%.
-
Here's the latest variant picture for New Zealand, to mid-January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at only 8%.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
-
Here's the latest variant picture for New Zealand, to mid-January.
In a chaotic scene, NB.1.8.1 "Nimbus", JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus" are all significant. This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at low frequencies so far.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20NZ.pdf -
Here's the latest variant picture for New Zealand, to early January.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
BA.3.2.* "Cicada" is also present, but at low frequencies so far.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
-
Here's the latest variant picture for the United States, to the end of November.
The XFG.* "Stratus" variant continued it’s dominance, but fell to 81% frequency.
NB.1.8.1 "Nimbus" was up slightly to 9%.
-
Here's the latest variant picture for New Zealand, to early December.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵 -
Here's the latest variant picture for Canada, to late November.
XFG.* "Stratus" continued to dominate, but fell to 67%.
NB.1.8.1 "Nimbus" rose slightly to 18%.
XFV.* grew to 10% nationally, however all the recent samples are from Ontario and recent volumes are very low, so that could just be a cluster from a healthcare or aged care setting.
#COVID19 #SARSCoV2 #Canada #XFG #Stratus #NB_1_8_1 #Nimbus #FLiRT
🧵 -
Here's the latest variant picture for New Zealand, to late November.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on disease-acquired immunity.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵 -
Here's the latest variant picture for New Zealand, to mid-November.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵 -
Here's the latest variant picture for New Zealand, to late October.
In a chaotic scene, NB.1.8.1 "Nimbus" is being challenged by JN.1.* +DeFLuQE (led by PE.1.4) and XFG.* "Stratus". This scenario raises the risk of rapid reinfections, for those relying on immunity from a recent infection.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵 -
Here's the latest variant picture for New Zealand, to mid-September.
NB.1.8.1 "Nimbus" has continued to dominate, finishing roughly flat at 58%.
The threat from JN.1.* +DeFLuQE has faded, finishing down at 23%.
XFG.* "Stratus" grew strongly to 22%.
#COVID19 #SARSCoV2 #NZ #NB_1_8_1 #Nimbus #DeFLuQE #XFG #Stratus
🧵 -
Here's the latest variant picture for Australia, to early September.
NB.1.8.1 "Nimbus" has continued to dominate, but fell back to finish at 46%.
It is under threat from the rebound in JN.1.* +DeFLuQE, which grew strongly to 39%.
-
Here's the latest variant picture for New Zealand, to early September.
NB.1.8.1 "Nimbus" has continued to dominate, finishing at 57%.
It looks under serious threat from JN.1.* +DeFLuQE, which finished at 36%.
-
Here's the latest variant picture for Australia, to late August.
NB.1.8.1 "Nimbus" has continued to dominate, but fell back to finish at 47%.
It looks under threat from the rebound in JN.1.* +DeFLuQE, which grew to 32%.